1. Transcriptomic analysis reveals mode of action of butyric acid supplementation in an intensified CHO cell fed‐batch process
   Markus Schulze et al, 2022, Biotechnology and Bioengineering CrossRef
2. Identification of core genes associated with prostate cancer progression and outcome via bioinformatics analysis in multiple databases
   Yutao Wang et al, 2020, PeerJ CrossRef
3. Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma
   Yongwen Luo et al, 2019, Aging CrossRef
4. Identification of novel biomarkers in prostate cancer diagnosis and prognosis
   Wenji Li et al, 2022, Journal of Biochemical and Molecular Toxicology CrossRef
5. Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer
   Zijian Zhou et al, 2022, Cancers CrossRef
6. Multi-Omics Reveal Additive Cytotoxicity Effects of Aflatoxin B1 and Aflatoxin M1 toward Intestinal NCM460 Cells
   Ya-Nan Gao et al, 2022, Toxins CrossRef
7. Screening of traditional Chinese medicine monomers as ribonucleotide reductase M2 inhibitors for tumor treatment
   Ya-Ya Qin et al, 2022, World Journal of Clinical Cases CrossRef
8. Cancer Fighting SiRNA-RRM2 Loaded Nanorobots
   Arjun Sharma et al, 2020, Pharmaceutical Nanotechnology CrossRef
9. RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway
   Yuheng Jiao et al, 2022, Biomolecules CrossRef
10. MicroRNA-520a Suppresses Pathogenesis and Progression of Non-Small-Cell Lung Cancer through Targeting the RRM2/Wnt Axis
    Yi Xie et al, 2021, Analytical Cellular Pathology CrossRef